Provided by Tiger Fintech (Singapore) Pte. Ltd.

Collegium Pharmaceutical

26.40
-0.3800-1.42%
Volume:29.83K
Turnover:788.99K
Market Cap:848.28M
PE:14.22
High:27.09
Open:26.60
Low:26.22
Close:26.78
Loading ...

Collegium Pharmaceutical Price Target Maintained With a $46.00/Share by Needham

Dow Jones
·
09 Apr

Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 30% ROE Better Than Average?

Simply Wall St.
·
02 Apr

A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

StockStory
·
02 Apr

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting

GlobeNewswire
·
27 Mar

Avalo Therapeutics Names Michael Heffernan as Board Chairman

MT Newswires Live
·
26 Mar

BRIEF-Avalo Therapeutics Appoints Michael Heffernan As Chairman Of The Board

Reuters
·
26 Mar

Collegium Pharmaceutical Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Dow Jones
·
24 Mar

Collegium Pharmaceutical: Undervalued Stock with Strong Growth Potential and Low Risk

TIPRANKS
·
24 Mar

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

StockStory
·
21 Mar

Collegium Pharmaceutical Appoints New Executive VP and General Counsel

TIPRANKS
·
17 Mar

BRIEF-Collegium Announces Updates To Its Board Of Directors And Executive Leadership Team

Reuters
·
17 Mar

Collegium Announces Updates to Its Board of Directors and Executive Leadership Team

THOMSON REUTERS
·
17 Mar

Collegium Pharmaceutical Inc - Gino Santini Appointed as Chairman of the Board

THOMSON REUTERS
·
17 Mar

Press Release: Collegium Announces Updates to its Board of Directors and Executive Leadership Team

Dow Jones
·
17 Mar

Have Collegium Pharmaceutical Insiders Been Selling Stock?

Simply Wall St.
·
13 Mar

Major Stock Sale by Collegium Pharmaceutical’s EVP!

TIPRANKS
·
07 Mar

Piper Sandler Reaffirms Their Hold Rating on Collegium Pharmaceutical (COLL)

TIPRANKS
·
06 Mar

Collegium Pharmaceutical's (NASDAQ:COLL) Solid Earnings Are Supported By Other Strong Factors

Simply Wall St.
·
06 Mar

Collegium to Participate in Upcoming Investor Conferences

GlobeNewswire
·
04 Mar

Collegium Pharmaceutical Full Year 2024 Earnings: In Line With Expectations

Simply Wall St.
·
01 Mar